Impact of
Impact of
About this item
Full title
Impact of
Author / Creator
Publisher
Future Medicine Ltd
Journal title
Pharmacogenomics, 2013-09, Vol.14 (12), p.1467-1480
Language
English
Formats
Publication information
Publisher
Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
studies have identified both midazolam and tacrolimus as dual CYP3A4 and CYP3A5 substrates.
; however, the
genotype has a marked impact on tacrolimus pharmacokinetics, whereas it seems not to affect midazolam pharmacokinetics. The aim of the current study was to explore this paradigm in a relevant clinical setting.
A case-control study in...
Alternative Titles
Full title
Impact of
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_futurescience_futuremedicine_10_2217_pgs_13_133
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_futurescience_futuremedicine_10_2217_pgs_13_133
Other Identifiers
ISSN
1462-2416
E-ISSN
1744-8042
DOI
10.2217/pgs.13.133
How to access this item
Log in as a Library member
